Variants studied for non-Hodgkin lymphoma

Minimum submission review status:		Collection method:
Minimum conflict level: Report conflict between different conditions
Gene type: Distinguish antisense genes from sense genes
Show significances as they were submitted (without aggregation into standard terms)
		ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic	likely pathogenic	uncertain significance	likely benign	benign	association	risk factor	not provided	total
85	204	90	16	32	2	3	3	422

Gene and significance breakdown #

Total genes and gene combinations: 71

Download table as spreadsheet

Gene or gene combination	pathogenic	likely pathogenic	uncertain significance	likely benign	benign	association	risk factor	not provided	total
NBN	8	11	39	10	20	0	0	1	84
TP53	5	70	0	0	0	0	0	0	74
PRF1	2	2	13	1	9	0	0	0	27
IKZF1	1	6	10	0	0	2	0	0	19
PAX5	1	13	2	0	0	0	0	0	15
BCL10	10	0	1	0	0	0	0	0	11
BRAF	3	8	0	0	0	0	0	0	10
FBXW7	0	10	0	0	0	0	0	0	10
NRAS	0	8	0	0	0	0	0	0	8
HRAS, LRRC56	0	7	0	0	0	0	0	0	7
MYC	4	3	0	0	0	0	0	0	7
B2M	1	5	0	0	0	0	0	0	6
CASP10	3	0	3	0	0	0	0	0	6
EZH2	0	6	0	0	0	0	0	0	6
GNB1	2	2	0	2	0	0	0	0	6
HAVCR2	1	1	3	0	1	0	3	0	6
RHOA	0	6	0	0	0	0	0	0	6
SF3B1	0	6	0	0	0	0	0	0	6
ERG	0	0	5	0	0	0	0	0	5
ATM	4	0	0	0	0	0	0	0	4
ATM, C11orf65	4	0	0	0	0	0	0	0	4
BCR	0	0	3	1	0	0	0	0	4
CDKN2A	0	2	2	0	0	0	0	0	4
INSL6, JAK2	4	0	0	0	0	0	0	0	4
PTPN11	1	3	0	0	0	0	0	0	4
RAD54L	1	1	1	1	0	0	0	0	4
ABL1	1	2	0	0	0	0	0	0	3
FLT3	3	0	0	0	0	0	0	0	3
JAK1, LOC126805749	0	3	0	0	0	0	0	0	3
LOC126860438, NBN	1	0	0	1	2	0	0	0	3
PIK3CA	0	3	0	0	0	0	0	0	3
PLCG2	0	3	0	0	0	0	0	0	3
PTEN	3	0	0	0	0	0	0	0	3
TET2	0	0	3	0	0	0	0	0	3
XPO1	0	3	0	0	0	0	0	0	3
BAX	2	0	0	0	0	0	0	0	2
BTK	1	0	0	0	0	0	0	1	2
DNMT3A	2	0	0	0	0	0	0	0	2
ETV6	1	1	0	0	0	0	0	0	2
FGFR1	0	2	0	0	0	0	0	0	2
JAK3	0	2	0	0	0	0	0	0	2
LOC105376032, PAX5	0	1	1	0	0	0	0	0	2
MAP2K1	0	2	0	0	0	0	0	0	2
NF1	0	1	1	0	0	0	0	0	2
PMS2	2	0	0	0	0	0	0	0	2
SF3B2	0	2	0	0	0	0	0	0	2
TBL1XR1	0	2	0	0	0	0	0	0	2
BRCA1	0	0	1	0	0	0	0	0	1
BRCA2	1	0	0	0	0	0	0	0	1
CD79B, GH-LCR	0	1	0	0	0	0	0	0	1
CDKN2B, LOC130001608	0	0	1	0	0	0	0	0	1
CHEK2	0	1	0	0	0	0	0	0	1
CREBBP	1	0	0	0	0	0	0	0	1
CRLF2	1	0	0	0	0	0	0	0	1
CSF3R	1	0	0	0	0	0	0	0	1
ERCC4	1	0	0	0	0	0	0	0	1
ETV6, LOC126861452	1	0	0	0	0	0	0	0	1
FOXO1	1	0	0	0	0	0	0	0	1
IL7R	0	1	0	0	0	0	0	0	1
JAK2, ZBTB20	0	1	0	0	0	0	0	0	1
KRAS	0	1	0	0	0	0	0	0	1
LOC107982234, WT1	0	1	0	0	0	0	0	0	1
LRRC41, RAD54L	0	0	1	0	0	0	0	0	1
MYD88	1	1	0	0	0	0	0	0	1
NOTCH1	1	0	0	0	0	0	0	0	1
NT5C2	0	0	0	0	0	0	0	1	1
PALB2	1	0	0	0	0	0	0	0	1
RAD54B	1	0	0	0	0	0	0	0	1
SF3A1	1	0	0	0	0	0	0	0	1
SOCS1	1	0	0	0	0	0	0	0	1
STAT3	1	0	0	0	0	0	0	0	1

Submitter and significance breakdown #

Total submitters: 33

Download table as spreadsheet

Submitter	pathogenic	likely pathogenic	uncertain significance	likely benign	benign	association	risk factor	not provided	total
Database of Curated Mutations (DoCM)	5	156	0	0	0	0	0	2	163
Fulgent Genetics, Fulgent Genetics	10	8	48	10	2	0	0	0	78
OMIM	40	0	0	0	0	0	3	0	43
Genomic Diagnostics Laboratory, National Institute of Medical Genomics	1	22	12	0	0	0	0	0	35
KCCC/NGS Laboratory, Kuwait Cancer Control Center	0	0	0	4	31	0	0	0	35
Department Of Pathology & Laboratory Medicine, University Of Pennsylvania	12	2	0	0	0	0	0	0	14
St. Jude Molecular Pathology, St. Jude Children's Research Hospital	3	2	8	0	0	0	0	0	13
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago	0	1	9	1	0	0	0	0	11
Wasik Lab, Fox Chase Cancer Center	3	5	1	0	0	0	0	0	9
Mendelics	3	0	2	1	0	0	0	0	6
Center for Advanced Molecular Diagnostics, Cytogenetics Laboratory, Brigham and Women's Hospital	4	0	0	0	0	0	0	0	4
Molecular Diagnostics Laboratory, University of Rochester Medical Center	0	0	3	0	0	0	0	0	3
Revvity Omics, Revvity	0	0	2	0	0	0	0	0	2
Diagnostic Molecular Genetics Laboratory, Memorial Sloan Kettering Cancer Center	2	0	0	0	0	0	0	0	2
Juno Genomics, Hangzhou Juno Genomics, Inc	0	2	0	0	0	0	0	0	2
Laboratorios de Investigación en Biología Molecular e Inmunología, Universidad Autónoma de Nayarit	0	0	0	0	0	2	0	0	2
University Health Network, Princess Margaret Cancer Centre	2	0	0	0	0	0	0	0	2
Baylor Genetics	0	1	0	0	0	0	0	0	1
Genetic Services Laboratory, University of Chicago	0	1	0	0	0	0	0	0	1
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital	0	1	0	0	0	0	0	0	1
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center	0	1	0	0	0	0	0	0	1
Genomic Research Center, Shahid Beheshti University of Medical Sciences	0	0	1	0	0	0	0	0	1
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center	0	0	1	0	0	0	0	0	1
Centre for Mendelian Genomics, University Medical Centre Ljubljana	0	0	1	0	0	0	0	0	1
Institute of Human Genetics, University of Leipzig Medical Center	0	1	0	0	0	0	0	0	1
Department of Pathology and Laboratory Medicine, Sinai Health System	0	0	1	0	0	0	0	0	1
Pele Pequeno Principe Research Institute, Faculdades Pequeno Principe	0	0	1	0	0	0	0	0	1
Mayo Clinic Genomics Laboratory, Mayo Clinic	1	0	0	0	0	0	0	0	1
Genome-Nilou Lab	0	0	0	0	1	0	0	0	1
Molecular Genetics Lab, CHRU Brest	0	1	0	0	0	0	0	0	1
3billion	0	0	1	0	0	0	0	0	1
GenomeConnect - Invitae Patient Insights Network	0	0	0	0	0	0	0	1	1
Solve-RD Consortium	0	1	0	0	0	0	0	0	1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.